Total Payments
$1,021
2024 Payments
$222.15
Companies
12
Transactions
51
Medicare Patients
375
Medicare Billing
$23,558
Payment Breakdown by Category
Food & Beverage$926.27 (90.7%)
Education$94.99 (9.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $926.27 | 50 | 90.7% |
| Education | $94.99 | 1 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $333.79 | 20 | $0 (2024) |
| Astellas Pharma US Inc | $194.32 | 5 | $0 (2024) |
| Novo Nordisk Inc | $122.39 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $100.57 | 6 | $0 (2023) |
| Lilly USA, LLC | $69.88 | 4 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $45.27 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $44.61 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $39.00 | 3 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.25 | 1 | $0 (2022) |
| Exact Sciences Corporation | $16.60 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.15 | 6 | Astellas Pharma US Inc ($94.99) |
| 2023 | $646.87 | 37 | ABBVIE INC. ($246.53) |
| 2022 | $152.24 | 8 | ABBVIE INC. ($45.13) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: PAIN | ||||||
| 11/22/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $45.27 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Diabetes | ||||||
| 02/06/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.99 | General |
| 12/08/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/27/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Biological | ||||||
| 10/19/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Cardio-renal | ||||||
| 09/27/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Respiratory | ||||||
| 09/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Biological | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: RESPIRATORY | ||||||
| 08/24/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Biological | ||||||
| 07/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Diabetes | ||||||
| 07/26/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Respiratory | ||||||
| 07/19/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Diabetes | ||||||
| 07/14/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 375 | 549 | $72,280 | $23,558 |
Total Patients
375
Total Services
549
Medicare Billing
$23,558
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 200 | $44,310 | $14,919 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $9,867 | $4,157 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 39 | $6,287 | $2,029 | 32.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,540 | $791.23 | 51.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 54 | $2,517 | $514.08 | 20.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $1,008 | $511.92 | 50.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 34 | $1,982 | $264.14 | 13.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $408.00 | $171.72 | 42.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 20 | 21 | $840.00 | $115.31 | 13.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 35 | $1,505 | $77.00 | 5.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 20 | 84 | $2,016 | $7.73 | 0.4% |
About Lauren Wells
Lauren Wells is a Gerontology healthcare provider based in Pleasant View, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2022. The National Provider Identifier (NPI) number assigned to this provider is 1316682750.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lauren Wells has received a total of $1,021 in payments from pharmaceutical and medical device companies, with $222.15 received in 2024. These payments were reported across 51 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($926.27).
As a Medicare-enrolled provider, Wells has provided services to 375 Medicare beneficiaries, totaling 549 services with total Medicare billing of $23,558. Data is available for 1 year (2023–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Gerontology
- Location Pleasant View, TN
- Active Since 04/30/2022
- Last Updated 03/02/2023
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1316682750
Products in Payments
- UBRELVY (Drug) $108.31
- Ozempic (Drug) $102.81
- Veozah (Drug) $80.58
- BOTOX (Biological) $77.29
- VRAYLAR (Drug) $76.08
- QULIPTA (Drug) $72.11
- BREZTRI (Drug) $69.42
- NUPLAZID (Drug) $45.27
- Kerendia (Drug) $44.61
- MOUNJARO (Drug) $39.29
- TRELEGY ELLIPTA (Drug) $39.00
- FARXIGA (Drug) $31.15
- XIFAXAN (Drug) $22.25
- Rybelsus (Drug) $19.58
- Myrbetriq (Drug) $18.75
- TRULICITY (Drug) $17.47
- Cologuard Collection Kit (Device) $16.60
- NURTEC ODT (Drug) $16.53
- Omnipod (Device) $16.05
- EMGALITY (Drug) $13.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.